Johnson Investment Counsel Inc / ABT
Johnson Investment Counsel Inc’s Abbott Laboratories Position
Does Johnson Investment Counsel Inc own Abbott Laboratories (ABT)? Yes — 1.02M shares worth $105M (+0.85% of its 13F portfolio) as of Q1 2026, up from 986.0K shares the prior filed quarter.
Position Value
$105M
Q1 2026
Shares
1.02M
% of Portfolio
+0.85%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.02M | $105M | +0.85% |
| Q4 2025 | 986.0K | $124M | +1.01% |
| Q3 2025 | 975.9K | $131M | +1.09% |
| Q2 2025 | 988.6K | $134M | +1.21% |
| Q1 2025 | 999.9K | $133M | +1.28% |
| Q4 2024 | 1.01M | $114M | +1.11% |
| Q3 2024 | 997.2K | $114M | +1.12% |
| Q2 2024 | 999.0K | $104M | +1.09% |
| Q4 2023 | 976.7K | $108M | +1.26% |
| Q3 2023 | 972.4K | $94M | +1.21% |
| Q2 2023 | 957.1K | $104M | +1.29% |
| Q1 2023 | 944.6K | $96M | +1.27% |
| Q4 2022 | 953.4K | $105M | +1.43% |
| Q3 2022 | 933.2K | $90M | +1.34% |
| Q2 2022 | 926.3K | $101M | +1.43% |
| Q1 2022 | 921.2K | $109M | +1.35% |
| Q4 2021 | 918.7K | $129M | +1.58% |
| Q3 2021 | 910.4K | $108M | +1.44% |
| Q2 2021 | 902.4K | $105M | +1.49% |
| Q1 2021 | 906.0K | $109M | +1.63% |
| Q4 2020 | 1.07M | $117M | +1.95% |
| Q3 2020 | 1.07M | $117M | +2.17% |
| Q2 2020 | 1.12M | $102M | +2.07% |
| Q1 2020 | 1.14M | $90M | +1.99% |
| Q4 2019 | 1.10M | $96M | +1.80% |
| Q3 2019 | 1.08M | $90M | +1.79% |
| Q2 2019 | 1.08M | $91M | +1.88% |
| Q1 2019 | 1.08M | $86M | +1.84% |
| Q4 2018 | 1.11M | $80M | +1.95% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Johnson Investment Counsel Inc’s full portfolio or all institutional holders of ABT.